Welcome to this installment of The AIDS Pandemic. I’m Dave Wessner.
Could our own bodies be producing potent inhibitors of HIV? According to research published in today’s issue of Cell, the answer may be ‘Yes.’ And these interesting findings eventually may lead to the development of new anti-retroviral drugs.
Since the isolation of HIV in 1983, numerous naturally occurring human factors have been postulated to have anti-HIV properties. Today, a group of researchers in Germany have added another factor to this list. By studying hundreds of small molecules isolated from human blood, the researchers identified a short peptide, or protein fragment, that effectively blocked HIV from infecting cells. Termed Virus-Inhibitory Peptide, or VIRIP, this peptide represents a small piece of a larger protein normally found in our blood – alpha1-anti-trypsin.
To demonstrate the inhibitory effects of VIRIP, the researchers infected cell lines with HIV-1, added VIRIP to the cells, and then determined how many additional cells subsequently became infected. VIRIP decreased the infection rate in a dose-dependent manner. In other words, when higher concentrations of VIRIP were used, the effect was greater. The effect also was very specific for HIV; the peptide did not block the infectivity of other types of viruses. Interestingly, the researchers showed that if they altered the VIRIP peptide slightly, it’s inhibitory properties increased dramatically. Finally, VIRIP was equally effective against strains of HIV that were resistant to other anti-retroviral drugs, yet resistance to VIRIP was not observed.
Mechanistically, it appears that VIRIP blocks HIV infection by binding to the viral protein gp41 and preventing fusion between the viral envelope and the cell membrane. An existing drug, T20, or Fuzeon, works in a similar manner.
The path from an initial discovery like this and a marketable drug is a long and winding path, filled with potholes. Promising candidate molecules rarely become FDA-approved drugs. So, the odds are against VIRIP. But, based on this report, it’s certainly worth keeping our eye on it.
Until next time, I’m Dave Wessner.
Friday, April 20, 2007
Subscribe to:
Post Comments (Atom)
Posts
3 comments:
We are a London based clinic in the process of trial treatments using a new herbal-based medicine effective in eliminating HIV virus. The medicine has been refined over the past 6 years. We have completed treatments for over 50 patients worldwide, all of whom have seen their viral count decrease significantly and CD4 count recover proportionally without any immediate or delayed side effects.
The duration of the treatment is normally between 3 – 12 months depending on the individual patient’s profile and the stage of the infection. This medicine has been proven to work consistently.
We are looking for candidates to join our on-going trial treatment programme. Our only objective is to expand our trial treatments so we can make it available to all as quickly as possible. Accordingly we are footing 100% of the cost of the medicine and shipping. In exchange we request that the patients provide us with periodic blood test results throughout the course of the treatment.
All of our patients’ information are automatically protected by confidentiality requirements as such we will not release any information onto any third parties without the patient’s direct personal consent.
We are investing our own money to pay for all of the costs of this program because this medicine has proven to work consistently and has huge potential.
Interested candidates can contact us via email at hiv.support.2001@googlemail.com
For more information visit: www.hivsupport.co.uk
Good Afternoon!!! the-aids-pandemic.blogspot.com is one of the best resourceful websites of its kind. I enjoy reading it every day. the-aids-pandemic.blogspot.com rocks!
Your blog keeps getting better and better! Your older articles are not as good as newer ones you have a lot more creativity and originality now keep it up!
Post a Comment